Research ExplorerJournalsANN ONCOL Publications

ANN ONCOL

101 - 108 out of 108Page size: 50

Publications

  1. 2003

  2. Intracranial metastases: therapeutic options.

    Westphal, M., Heese, O. & de Wit, M., 2003, In: ANN ONCOL. 14, 3, p. 4-10 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2002

  4. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.

    Hegewisch-Becker, S., Gruber, Y., Corovic, A., Pichlmeier, U., Atanackovic, D., Nierhaus, A. & Hossfeld, D. K., 2002, In: ANN ONCOL. 13, 8, p. 1197-1204 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2001

  6. 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

    de Wit, M., Bohuslavizki, K. H., Buchert, R., Bumann, D., Clausen, M. & Hossfeld, D. K., 2001, In: ANN ONCOL. 12, 1, p. 29-37 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 1998

  8. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.

    Hegewisch-Becker, S., Staib, F., Löning, T., Pichlmeier, U., Kröger, N., Reymann, A. & Hossfeld, D. K., 1998, In: ANN ONCOL. 9, 1, p. 85-93 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 1996

  10. Mobilisation kinetics of primitive haemopoietic cells following G-CSF with or without chemotherapy for advanced breast cancer

    Baumann, I., Swindell, R., Van Hoeff, M. E., Dexter, T. M., de Wynter, E., Lange, C., Luft, T., Howell, A. & Testa, N. G., 01.12.1996, In: ANN ONCOL. 7, 10, p. 1051-7 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.

    Favrot, M. C., Ambros, P., Schilling, F., Frappaz, D., Combaret, V., Berthold, F., Dominici, C., Erttmann, R., Esteve, J., Jenkner, A., Kerbl, R., Mann, J., Mathieu, P., Parker, L., Powell, J. & Philip, T., 1996, In: ANN ONCOL. 7, 6, p. 607-611 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients.

    Berthold, F., Hero, B., Breu, H., Christiansen, H., Erttmann, R., Gnekow, A., Herrmann, F., Klingebiel, T., Lampert, F., Müller-Weihrich, S. & Weinel, P., 1996, In: ANN ONCOL. 7, 2, p. 183-187 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 1994

  14. Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy

    Van Hoef, M. E., Baumann, I., Lange, C., Luft, T., de Wynter, E. A., Ranson, M., Morgenstern, G. R., Yvers, A., Dexter, T. M. & Testa, N. G., 01.03.1994, In: ANN ONCOL. 5, 3, p. 217-24 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next